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Cefadroxil, an oral antimicrobial, presents few techniques optimized for the reduction of solvents and toxic residues and/or non-
use of them. So, a quantitative, new and miniaturized method for determination of cefadroxil monohydrate in capsules has been 
developed and validated by spectrophotometric method in the visible region according to the international guidelines. The 
analyzes were performed using microplates containing 96 wells, 1 % of phenolphthalein and sodium hydroxide 0.1 M as reagent 
at 552 nm. The method was (i) linear in the range of 15-115 µg mL
-1
, (ii) selective when comparing standard, sample, adjuvants 
and color reagent, (iii) precise with deviations below 4 %, (iv) accurate when comparing the proposed method with the HPLC 
method, (v) robust by making small and deliberate modifications to the method, (vi) besides being fast, low cost, eco-friendly and 
generates minimal amount of waste. The method can be applied to the routine quality control of cefadroxil monohydrate in 
capsules and an effective and accessible alternative that contemplates the concepts of current and sustainable green analytical 
chemistry. 
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Introduction  
 
Cefadroxil is a semi-synthetic antibiotic intended for oral 
administration and belongs to the first generation group of 
cephalosporins [1-2]. It has bactericidal activity by 
inhibiting the synthesis of the cell wall of the bacterium 
being used in the treatment of infections caused mainly by 
Gram-positive bactéria [3-7]. The drug is chemically known 
as (6R,7R)-7-[(2R)-2-amino-2-(4-hydroxyphenyl) acetyl 
amino]-3-methyl-8-oxo-5-tia-1azabicyclo[4.2.0]oct-2-eno-2-
carboxilic acid [8]. 
Infections caused by microorganisms that are vulnerable to 
cefadroxil are common in society and reach a large part of 
the population. Due to the recurrent sale of this oral 
cephalosporin, studies become fundamental, mainly on 
quality control, which involves research and development of 
highly relevant analytical methods for the optimization of 
the analyzes in the industries and the guarantee of the 
quality of the already commercialized product [9-10]. 
Although there are several studies in the literature for the 
development of analytical methods for the identification and 
quantification of cefadroxil, there are few techniques 
optimized for the reduction of solvents and toxic residues 
and/or non-use of them. It is of utmost importance to replace 
analytical methods considered harmful to the environment 
and operators, by efficient and safe methods that present a 
significant reduction of the use of organic solvents, cost and 
energy expenditure for the industries [11]. 
So, a miniaturized spectrophotometric method in the region 
visible using microplate was chosen to quantify and identify 
the cefadroxil monohydrate in capsules. 
 
Experimental 
 
Materials 
 
 
 
The standard was cefadroxil monohydrate (purity 93.03 %) 
and the samples were cefadroxil monohydrate 500 mg 
capsules. They were kindly supplied by EMS 
pharmaceutical company (Hortolândia, SP, Brazil). 
Adjuvants present in the capsules of cefadroxil (magnesium 
stearate, croscarmellose sodium and talc) were kindly 
supplied by Pharmacotechnic Laboratory of the School of 
Pharmaceutical Sciences from São Paulo State University 
(UNESP). 
Reagents (phenolphthalein, analytical grade – Synth® - and 
sodium hydroxide, analytical grade – Dinâmica®) were 
obtained and prepared by the Quality Control Laboratory of 
the School of Pharmaceutical Sciences from São Paulo State 
University (UNESP). 
 
Spectrophotometric conditions  
 
The UV-Visible spectrophotometer used was the model 
SPECTRO star® Nano (BMG LabTech, Germany) and a 
96-well microplate was used for measuring absorbance at a 
wavelength of 552 nm. The software used as support for 
construction the calibration curves was Microsoft Excel 
(2010). 
 
Solutions 
 
Preparation of cefadroxil standard  
An equivalent of 10 mg cefadroxil standard was weighed 
and transferred to a 10 mL volumetric flask and the volume 
was completed with ultrapure water, in order to obtain a 
stock solution of 1000 µg mL
-1
. Aliquots of 75, 175, 275, 
375, 475 and 575 μL of this solution were transferred to 5 
mL volumetric flasks, and the volumes were completed with 
ultrapure water, in order to obtain working solutions of 15, 
35, 55, 75, 95 and 115 µg mL
-1
, respectively. All the 
solutions were prepared in triplicate. 
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Preparation of cefadroxil sample  
After accurate weighing of twenty capsules of cefadroxil 
monohydrate, an equivalente of 10 mg cefadroxil was 
weighed and transferred to a 10 mL volumetric flask and the 
volume was completed with ultrapure water, in order to 
obtain a stock solution of 1000 µg mL
-1
. Without the 
filtration step, aliquots of 75, 175, 275, 375, 475 and 575 μL 
of this solution were transferred to 5 mL volumetric flasks, 
and the volumes were completed with ultrapure water, in 
order to obtain working solutions with a concentrations of 
15, 35, 55, 75, 95 and 115 µg mL
-1
. All the solutions were 
prepared in triplicate. 
 
Preparation of adjuvants solution  
A mixture of adjuvants (magnesium stearate, croscarmellose 
sodium and talc) present in the sample of capsules was 
prepared in laboratory using amounts of pharmaceutical 
grade in accordance with the production of the formulation 
of cefadroxil monohydrate 500 mg capsules. Stock 
adjuvants solution was prepared in the same way as the 
cefadroxil standard and sample to evaluate the interference 
of the adjuvants in the method. 
 
Preparation of color reagent  
The reagents used to development and validation of this 
method were phenolphthalein and sodium hydroxide 
(NaOH), analytical grade. Other reagents were tested, such 
as ascorbic acid 3 %, methyl red 0.1 % and bromothymol 
blue 1 % However, phenolphthalein 1 % and NaOH 0.1 M 
was the only one that interacted with the cefadroxil 
molecule. Several concentrations of this dye were performed 
and the combination of 800 μL of phenolphthalein 1 % and 
400 μL of NaOH 0.1 M in a 25 mL volumetric flask (the 
volume was completed with ultrapure water) was the one 
that best interacted with the drug, presenting absorbances of 
0.2 to 0.8 and linear correlation between them and drug 
concentrations, according to Lambert Beer's Law. 
Phenolphthalein and NaOH solution were prepared using the 
molar mass, 318.32 and 40.00 g mol
-1
, respectively. 
 
Obtaining of analytical curve 
 
Solutions of 15, 35, 55, 75, 95 and 115 µg mL
-1
 of 
cefadroxil standard were prepared using ultrapure water. 
Aliquots of 100 μL of these solutions were added to the 
microplate and 100 μL of the color reagent was added to 
each well contained working solutions. The absorbances 
were measured at 552 nm, at shaking in time of 2 minutes 
with rotation of 500 rpm. 
The stability of the color complex formed depends on the 
amount of drug present in the solution; the higher the 
amount of drug, the faster the loss of color and vice versa. 
For this reason, the stipulation of time is fundamental 
(including it was tested in the robustness parameter), in this 
case the chosen shaking time was 2 minutes. 
 
Method validation  
 
The quantification method was validated according by the 
following parameters: specificity, linearity, limits of 
detection (LOD) and quantification (LOQ), precision, 
accuracy and robustness. All carried out according to the 
International Conference on Harmonization (ICH) and US 
Food and Drug Administration (FDA) [12-13]. 
 
Selectivity 
Selectivity of the method was determined by a mixture of 
the adjuvants (magnesium stearate, croscarmellose sodium 
and talc) present in the cefadroxil monohydrate capsules, to 
verify if the adjuvants would interfere in the quantification 
of cefadroxil using the proposed method. Solutions of the 
adjuvants with mass equivalent to the capsules were 
prepared for the determination of the spectrum. 
 
Linearity, Limits of Detection (LOD) and Limits of 
Quantitation  
Tree different calibration curves were constructedin 
triplicate and obtained on tree different days with six 
concentrations (15, 35, 55, 75, 95 and 115 µg mL
-1
) of 
cefadroxil standard. The linearity parameter was evaluated 
according to regression lines using least squares and 
ANOVA to calculate the calibration equation and 
correlation coefficient, and the standardized residual graph. 
The limits of detection and quantitation were obtained by 
the Equations 1 and 2 as described in the literature [12]. 
 
Equation 1: LOD: 3.3 σ/S 
Equation 2: LOQ: 10 σ/S 
 
Where: σ: Standard deviation of the analytic curve intercept;  
S: Average of the analytic curve slope 
 
Precision 
Three types of precision were evaluated in this method. The 
repeatability (intra-day precision) was performed by the 
preparation and reading of six differents solutions of 
cefadroxil standard at the concentration of 55 µg mL
-1
, on 
the same day, analyzing the RSD% among such 
determinations; the intermediate (inter-day precision) was 
evaluated under the same conditions as above, on three 
different days and its statistical evaluation was based on the 
ANOVA single factor; and inter-analysts precision was 
performed by the preparation and reading of six differents 
solutions of cefadroxil standard at the concentration of 55 
µg mL
-1
, on the same day, but done by two different 
analysts, the statistical evaluation was based on the F-test 
(Snedecor) and t-test (Student). 
 
Accuracy 
The accuracy of the method was performed through 
a comparative analysis of the methods [12], in which the 
results obtained in this validation were compared with a 
second physicochemical method (High Performance Liquid 
Chromatography - HPLC) already validated for the drug, in 
which it presents similar concentrations worked on the linear 
curve [14]. The comparative assay was performed using 
cefadroxil sample solution. Six content analyzes were 
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performed using HPLC and UV methods. The content was 
calculated by Equations 3 and 4. The concentration used for 
both methods was 55 µg mL
-1 
and the statistical evaluation 
was performed through the F-test (Snedecor) and t-test 
(Student). 
 
Equation 3:               
Equation 4:               
 
Where: SC: sample concentration (µg mL
-1
); AS: 
absorbance of the sample; CRS: concentration of the 
reference substance (µg mL
-1
); ASR: absorbance of reference 
substance; Ct: theoretical concentration of the sample (µg 
mL
-1
) 
 
Robustness 
The robustness of the method was evaluate through three 
parameters varied independently: wavelength (554 and 550 
nm); source of deionized water (two different laboratories) 
and shaking time (180 and 60 seconds). The results obtained 
by varying this parameter were analyzed by F-test 
(Snedecor) and t-test (Student). 
 
Results 
 
Method Validation 
 
Selectivity 
The selectivity of the method was proven because the 
adjuvants present in the cefadroxil monohydrate capsules 
did not interfere in the quantification and identification of 
the drug. 
Figure 1 allow to verify that color reagent containing 1 % 
phenolphthalein and NaOH 0.1 M reacts with the drug 
molecule resulting in a decrease in absorbance as the drug 
concentrations increase, exhibiting likewise that the 
adjuvants do not react with the color reagent in the same 
way as the drug, which prover their non-interference in the 
quantification of cefadroxil. 
The mechanism of the method was based on the acid-base 
reaction. The cefadroxil has an acid character and by 
including a reagent with a basic character and a dye it was 
possible to establish a relation of the amount of drug with 
the observed color of the solution. The higher the amount of 
cefadroxil, the more drug available for reaction and the 
weaker the color of the solution after 2 minutes of reaction. 
The lower the amount of cefadroxil, the less drug available 
for reaction and the more intense the color of the solution 
after 2 minutes of reaction. 
 
Linearity, Limits of Detection (LOD) and Limits of 
Quantitation  
The analytical curve for the cefadroxil standard was derived 
from the mean values of the absorbances with respect to the 
concentrations from 15 to 115 µg mL
-1
, as shown in Figure 
2. The analysis of the significance of the regression is 
represented by Table 1 and the standardized residual graph 
is found in Figure 2. 
The method presented linear with correlation coefficient (r) 
of 0.9996 and the statistical data showed no significant 
linearity deviation at a 5 % level of variance, with Fcalculated 
(0.04) lower than the Fcritical (3.26). Limits of detection and 
quantification were calculated to determine the sensitivity of 
the method. The value found for the detection limit was 1.67 
µg mL
-1
, and the limit of quantification was 5.07 µg mL
-1
. 
 
 
 
Figure 1. Evaluation of the selectivity of the method. (A) Spectrum 
exhibiting no interference of the adjuvants with the reagent and (B) 
spectrum exhibiting the reaction of the reagent with the cefadroxil. 
 
 
Table 1. Variance analysis of the absorbance values used to 
construct the analytical curve of the cefadroxil monohydrate by 
spectrophotometric method 
Sources of 
variation 
Degrees 
of 
freedom 
Sum of 
squares 
Variance Fcalculated Fcritical 
Between 
concentration 
5 0.50799 0.10160 278.94* 3.11 
Linear 
regression 
1 0.50711 0.50711 
1393.44
* 
4.75 
Linearity 
deviations 
4 0.00088 0.0002205 0.32 3.26 
Residue 12 0.00437 0.0003642 --- --- 
Total 17 0.51236 --- --- --- 
 
 
Figure 2. (A) Analytical curve of the cefadroxil monohydrate by 
spectrofotometric method. (B) Residual graph for the analysis of 
the linearity of the spectrophotometric method. 
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Precision 
The results obtained in the statistical analyzes are presented 
in Table 2. The precision parameter was in accordance with 
the acceptance criteria defined in international guidelines 
[12-13]. The analysis of intra-day precision showed a 
relative standard deviation less than 3 %. The analysis of 
variance of the values of the inter-day precision showed 
Fcalculado (1.52) less than Fcritical (3.11). The inter-analyst 
precision was proved by the F-test (Snedecor) and t-test 
(Student), in which tcalculated (0.29) was less than tcritical (2.23). 
 
 
 
 
 
 
Accuracy 
 
The results of the accuracy by content determination 
performed through the comparison between methods are 
presented in Table 3. The tests were performed by the 
spectrophotometric and chromatographic techniques with 
the same theoretical values of concentrations, resulting in 
values of sample contents of the cefadroxil monohydrate 
capsules of 99.95 % and 99.82 %, respectively. The 
statistical comparison of the content values found by the two 
methods was performed by the ttest (Student). The tcalculated 
(0.15) was lower than the tcritical (2.22), showing that there 
was no statistically significant difference between the 
values. 
 
Table 2. Results of statistical evaluation of precision for cefadroxila monohydrate capsules by spectrophotometric method. 
Precision 
Results 
Average RSD (%) 
1 2 3 4 5 6 
Intra-day 0.594 0.625 0.627 0.597 0.627 0.639 0.618 2.96 
Inter-day* 
0.594 0.625 0.627 0.597 0.627 0.639 
0.617 3.14 0.581 0.628 0.630 0.607 0.644 0.603 
0.621 0.623 0.58 0.632 0.638 0.613 
Between 
analysts** 
0.621 0.623 0.580 0.632 0.638 0.613 
0.616 2.81 
0.619 0.618 0.600 0.627 0.632 0.593 
*ANOVA = Fcalculated 1.52 < Fcritical 3.11 
**ttest (Student) = tcalculated 0.29 < tcritical 2.23 
 
 
 
 
 
 
 
 
Table 3. Determination of the accuracy of the proposed spectrophotometric method. 
Evaluation 
Methods 
Spectrophotometric HPLC 
Content determination (%) 
  
1 98.22 100.59 
2 102.44 98.97 
3 100.32 100.59 
4 98.69 97.71 
5 100.34 101.92 
6 99.72 99.13 
Average 99.95 99.82 
RSD (%) 1.49 1.50 
F-test (Snedecor) and  
t-test (Student) 
Fcalculated 1.01 < 5.05 Fcritical 
tcalculated 0.15 < 2.22 tcritical 
RSD = relative standard deviation 
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Robustness 
The robustness of the miniaturized spectrophotometric 
method was confirmed by the deliberate change of some 
parameters, shown in the Table 4. For shaking time 
parameter varied, the results did not robust under the 
conditions tested. This indicates that the method is 
extremely sensitive to the time that the cefadroxil is exposed 
in contact with the color reagent. The time exceeded for this 
reaction influences directly in the analytical methodology. 
For this reason, it is important to standardize the shaking 
time in 120 seconds. This was the stipulated time to occur 
acid-base reaction and the ratio of cefadroxil concentration 
and absorbance value to be linear. However, the change in 
wavelength to 550 nm and 554 nm had no significant impact 
on absorbance values (tcalculated < tcritical) compared to the 
normal condition (552 nm). Likewise, the change in the 
source of water used in the preparation of the samples was 
also not significant (tcalculated < tcritical). 
 
Table 4. Evaluation of the robustness of the proposed 
spectrophotometric method using t-test (Student) 
Parameters 
Condition t-test (Student) 
Normal Modified tcalculated tcritical 
Wavelength 
(nm) 
552 
554 0.22 2.77 
550 1.55 2.77 
Shaking time 
(seconds) 
120 
180 9.79* 2.77 
60 6.48* 2.77 
Water source MC PC 1.31 2.77 
PC - laboratory of physical-chemical control; MC- laboratory of 
microbiological control; * non-robust results 
 
Discussion 
 
The validation of methods is essential to ensure the quality 
assurance of the manufactured products, making new 
equipment and new methods of a process to be developed 
with reliable and certified results [15]. 
Many studies are carried out on UV-visible 
spectrophotometric for the identification and quantification 
of cefadroxil [16-22], however, in none of the studies has 
the technique been presented in microplates, which makes 
the choice of the method safe to be performed and propitious 
for the continuity of analyzes that contribute to green 
analytical chemistry. 
Ultraviolet and visible spectrophotometryis one of the most 
frequently employed technique in pharmaceutical analysis 
[23-29]. Absorption spectrofotometric in the ultraviolet 
region refers to absorption or reflectance in the visible range 
(400-800 nm) which directly affects the color of the 
chemicals used in the tecnique. In the region of the 
electromagnetic spectrum, molecules and atoms will 
undergo electronic transitions that will pass from the ground 
state to the excited state [30]. The equipment shall record in 
a matter of seconds the absorptivity or transmittance data 
obtained as a function of the wavelength. 
The proposed method can be considered valid for the 
quantitative determination of cefadroxil monohydrate in 
capsules. It showed linearity in the range of 15 to 115 µg 
mL
-1
; selectivity when comparing standard, sample, 
adjuvants and color reagent; precision with deviations below 
4 %; accuracy when comparing the proposed method with 
the HPLC method; robustness by making small and 
deliberate modifications to the method. It is also an 
ecologically correct method, easy to handle, fast, low cost, 
does not use organic solventes, does not need sample pre-
treatment and the waste generation is minimal. These 
characteristics include it in the current and sustainable green 
analytical chemistry for the analysis of pharmaceutical 
products. 
 
Conclusions 
 
For the first time, a miniaturized spectrophotometric method 
was validated for the determination of the cefadroxil 
monohydrate in capsules. The method was selective, linear, 
precise, accurate and robust. It contributes to green 
analytical chemistry, since it is fast, low cost, reliable, does 
not use organic solvents, waste generation is minimal, being 
an eco-friendly alternative to the routine analyzes of quality 
control of this pharmaceutical product. 
syndromes.  
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